Innovating For The Future: Accelerating The Arrival Of Immuno-Oncology 2.0

There is a growing interest in a proposed new era of optimized cell therapy manufacturing—referred to as “immuno-oncology 2.0”. This comes alongside growing excitement about the effect of immuno-oncology on modern medicine and several next-generation therapeutics on the horizon. However, before further progress is made, there remain several challenges facing the development of optimized manufacturing processes.

Here we analyze how the innovation of analytical equipment, automation of processes, and scalability of manufacturing are the three key areas where development and collaboration are needed.